Kinetic analysis of Mycobacterium tuberculosis-specific cytokine production by PBMC in adults after BCG vaccination

Journal of Infection and Chemotherapy

Volumn 11, Issue 1, 2005, Pages 18-23

  Nabeshima, Shigeki ^a   Murata, Masayuki ^a   Yamaji, Kouzaburo ^a   Chong, Yong ^a   Nomoto, Mari ^c   Hayashi, Jun ^a,b  

^a KYUSHU UNIVERSITY HOSPITAL   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

^c UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

Author keywords

Cytokine; Tuberculin skin test; Vaccination

Indexed keywords

BACTERIAL VACCINE; BCG VACCINE; GAMMA INTERFERON; INTERLEUKIN 10; TUBERCULIN;

ADULT; ARTICLE; BCG VACCINATION; CELL CULTURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFICACY; FEMALE; HEALTH CARE PERSONNEL; HUMAN; IMMUNE DEFICIENCY; IMMUNOLOGY; INFANCY; INTERFERON PRODUCTION; LYMPHADENITIS; MALE; MYCOBACTERIUM TUBERCULOSIS; PERIPHERAL BLOOD MONONUCLEAR CELL; SKIN ULCER; TUBERCULIN TEST; TUBERCULOSIS;

EID: 15044356811     PISSN: 1341321X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10156-004-0357-8     Document Type: Article

References (34)

1. Sudre P, ten Dam G, Kochi A. Tuberculosis: a global overview of the situation today. Bull World Health Organ 1992;70:149-59.
2. Dannenberg AM Jr. Delayed-type hypersensitivity and cell-mediated immunity in the pathogenesis of tuberculosis. Immunol Today 1991;12:228-33.
3. Toossi Z, Kleinhenz ME, Ellner JJ. Defective interleukin-2 production and responsiveness in human pulmonary tuberculosis. J Exp Med 1986;163:1162-72.
4. Hirsch CS, Toossi Z, Othieno C, Johnson JL, Schwander SK, Robertson S, et al. Depressed T-cell interferon-gamma responses in pulmonary tuberculosis: analysis of underlying mechanisms and modulation with therapy. J Infect Dis 1999;180:2069-73.
5. Huebner RE. BCG vaccination in the control of tuberculosis. Curr Top Microbiol Immunol 1996;215:263-82.
6. McMurray DN, Collins FM, Dannenberg AM Jr, Smith DW. Pathogenesis of experimental tuberculosis in animal models. Curr Top Microbiol Immunol 1996;215:157-79.
7. Black GF, Dockrell HM, Crampin AC, Floyd S, Weir RE, Bliss L, et al. Patterns and implications of naturally acquired immune responses to environmental and tuberculous mycobacterial antigens in northern Malawi. J Infect Dis 2001;184:322-9.
8. Rodrigues LC, Diwan VK, Wheeler JG. Protective effect of BCG against tuberculous meningitis and miliary tuberculosis: a meta-analysis. Int J Epidemiol 1993;22:1154-8.
9. Brewer TF, Colditz GA. Bacille Calmette-Guerin vaccination for the prevention of tuberculosis in health care workers. Clin Infect Dis 1995;20:136-42.
10. Marcus AM, Rose DN, Sacks HS, Schechter CB. BCG vaccination to prevent tuberculosis in health care workers: a decision analysis. Prev Med 1997;26:201-7.
11. Raitio M, Tala E. Tuberculosis among health care workers during three recent decades. Eur Respir J 2000;15:304-7.
12. Karakonga Prevention Trial Group. Randomised controlled trial of single BCG, repeated BCG, or combined BCG and killed Mycobacterium leprae vaccine for prevention of leprosy and tuberculosis in Malawi. Karonga Prevention Trial Group. Lancet 1996;348:17-24.
13. Leung CC, Tam CM, Chan SL, Chan-Yeung M, Chan CK, Chang KC. Efficacy of the BCG revaccination programme in a cohort given BCG vaccination at birth in Hong Kong. Int J Tuberc Lung Dis 2001;5:717-23.
14. Sterne JA, Rodrigues LC, Guedes IN. Does the efficacy of BCG decline with time since vaccination? Int J Tuberc Lung Dis 1998;2:200-7.
15. Brooks JV, Frank AA, Keen MA, Bellisle JT, Orme IM. Boosting vaccine for tuberculosis. Infect Immun 2001;69:2714-7.
16. Barbosa T, Arruda S, Fernandes BD, Carvalho LP, Cardoso S, Cunha S, et al. BCG (Bacille of Calmette-Guerin) revaccination leads to improved in vitro IFN-gamma response to mycobacterial antigen independent of tuberculin sensitization in Brazilian schoolage children. Vaccine 2003;21:2152-60.
17. Le CT. Cost-effectiveness of the two-step skin test for tuberculosis screening of employees in a community hospital. Infect Control 1984;5:570-2.
18. Stewart CJ. Skin sensitivity to human, avian and BCG PPDs after BCG vaccination. Tubercle 1968;49:84-91.
19. Narain R, Nair SS, Rao GR, Chandrasekhar P, Lal P. Enhancing of tuberculin allergy by previous tuberculin testing. Bull World Health Organ 1966;34:623-38.
20. Huebner RE, Schein MF, Bass JB Jr. The tuberculin skin test. Clin Infect Dis 1993;17:968-75.
21. Black GF, Fine PEM, Warndorff DK, Floyd S, Weir RE, Blackwell JM, et al. Relationship between IFN-gamma and skin test responsiveness to Mycobacterium tuberculosis PPD in healthy, non-BCG-vaccinated young adults in Northern Malawi. Int J Tuberc Lung Dis 2001;5:664-72.
22. Floyd S, Ponnighaus JM, Bliss L, Nkhosa P, Sichali L, Msiska G, et al. Kinetics of delayed-type hypersensitivity to tuberculin induced by bacille Calmette-Guerin vaccination in northern Malawi. J Infect Dis 2002;186:807-14.
23. Fulton SA, Johnsen JM, Wolf SF, Sieburth DS, Boom WH. Interleukin-12 production by human monocytes infected with Mycobacterium tuberculosis: role of phagocytosis. Infect Immun 1996;64:2523-31.
24. Dalton DK, Haynes L, Chu CQ, Swain SL, Wittmer S. Interferon-gamma eliminates responding CD4 T cells during mycobacterial infection by inducing apoptosis of activated CD4 T cells. J Exp Med 2000;192:117-22.
25. Worku S, Hoft DF. Differential effects of control and antigen-specific T cells on intracellular mycobacterial growth. Infect Immun 2003;71:1763-73.
26. Boussiotis VA, Tsai EY, Yunis EJ, Thim S, Delgado JC, Dascher CC, et al. IL-10-producing T cells suppress immune responses in anergic tuberculosis patients. J Clin Invest 2000;105:1317-25.
27. Toossi Z, Gogate P, Shiratsuchi H, Young T, Ellner JJ. Enhanced production of TGF-beta by blood monocytes from patients with active tuberculosis and presence of TGF-beta in tuberculous granulomatous lung lesions. J Immunol 1995;154:465-73.
28. Nabeshima S, Nomoto M, Matsuzaki G, Kishihara K, Taniguchi H, Yoshida S, et al. T-cell hyporesponsiveness induced by activated macrophages through nitric oxide production in mice infected with Mycobacterium tuberculosis. Infect Immun 1999;67:3221-6.
29. de Jong R, Altare F, Haagen IA, Elferink DG, Boer T, van Breda Vriesman PJ, et al. Severe mycobacterial and Salmonella infections in interleukin-12 receptor-deficient patients. Science 1998;280:1435-8.
30. Bellamy R, Ruwende C, Corrah T, McAdam KP, Whittle HC, Hill AV. Variations in the NRAMP1 gene and susceptibility to tuberculosis in West Africans. N Engl J Med 1998;338:640-4.
31. Wilkinson RJ, Llewelyn M, Toossi Z, Patel P, Pasvol G, Lalvani A, et al. Influence of vitamin D deficiency and vitamin D receptor polymorphisms on tuberculosis among Gujarati Asians in west London: a case-control study. Lancet 2000;355:618-21.
32. Altare F, Ensser A, Breiman A, Reichenbach J, Baghdadi JE, Fischer A, et al. Interleukin-12 receptor beta-1 deficiency in a patient with abdominal tuberculosis. J Infect Dis 2001;184:231-6.
33. Stein CM, Guwatudde D, Nakakeeto M, Peters P, Elston RC, Tiwari HK, et al. Heritability analysis of cytokines as intermediate phenotypes of tuberculosis. J Infect Dis 2003;187:1679-85.
34. Xing Z. The hunt for new tuberculosis vaccines: anti-TB immunity and rational design of vaccines. Curr Pharm Des 2001;7:1015-37.